Pnc Financial Services Group, Inc. Opti Nose, Inc. Transaction History

Pnc Financial Services Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.17 - $1.94 $53 - $89	46 Added 117.95%	85 $0
Q4 2023 Feb 09, 2024	SELL	$1.02 - $1.47 $11,562 - $16,663	-11,336 Reduced 99.66%	39 $0
Q3 2023 Nov 13, 2023	BUY	$0.93 - $1.38 $10,578 - $15,697	11,375 New	11,375 $13,000
Q3 2021 Nov 05, 2021	SELL	$2.35 - $3.16 $672 - $903	-286 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$6.27 - $11.41 $5,555 - $10,109	-886 Reduced 75.6%	286 $2,000
Q3 2019 Nov 08, 2019	SELL	$4.75 - $8.38 $19 - $33	-4 Reduced 0.34%	1,172 $8,000
Q2 2019 Aug 09, 2019	BUY	$6.4 - $10.94 $7,027 - $12,012	1,098 Added 1407.69%	1,176 $0
Q1 2018 May 11, 2018	BUY	$15.91 - $20.82 $1,240 - $1,623	78 New	78 $0

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $45M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.